Medication Adherence Therapy for Opioid Abusing Pain Patients
CompletedPhase 1, Phase 2NCT00249587
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to develop and pilot test a combined behavioral and pharmacological intervention designed to decrease pain, functional interference, and drug abuse while increasing medication adherence.
Study details
- Official title
- Medication Adherence Therapy for Opioid Abusing Pain Patients
- Conditions
- Pain
- Chronic Disease
- Prescription Opioid Abuse
- Interventions
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Start date
- 2000-09
- Primary completion
- 2005-09
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Uninterrupted pain of at least 6 months duration * Pain is continuous, rather than intermittent * Pain in the severe range (VAS = 7-10) while medicated * Poor response to non-pharmacological interventions for pain (if appropriate) * One or more of the following pain diagnoses: (a) back/neck pain; (b) myofacial pain; (c) neuropathic pain (e.g., diabetic or AIDS neuropathy, Complex regional pain syndrome); (d) arthritic pain; (e) MS; or (f) sickle cell (must meet chronicity criteria) * Evidence of tolerance/physiological dependence on opioid analgesics * Current opioid use disorder (DSM-IV criteria) * Continuous use of opioid analgesics for a minimum of 6 months prior to referral. \[Note: This is consistent with minimum 6-month requirement for diagnosis of chronic pain\]. * Minimum of 2 signs/symptoms of medication mismanagement identified by the Referring MD (PROBLEMS WITH PAIN MEDS checklist) Exclusion Criteria: * Please contact site regarding exclusion criteria for this study.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00249587